Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions

Felipe de Sousa e Melo, Xin Wang, Marnix Jansen, +15

Nature Medicine

Tumor BiologyMolecularly Distinct SubtypeGastrointestinal OncologyMedicinePoor-prognosis Colon Cancer +9

Immune Escape in Breast Cancer During <i>In Situ</i> to Invasive Carcinoma Transition

Carlos R. Gil Del Alcazar, Sung Jin Huh, Muhammad B. Ekram, +27

Cancer Discovery

Phylogenetic Quantification of Intra-tumour Heterogeneity

Roland F. Schwarz, Anne Trinh, Botond Sipos, +3

PLoS Computational Biology

GeneticsPathologyGenomicsHeterogeneity QuantificationPhylogenetic Analysis +22

Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry

Anne Trinh, Kari Trumpi, Felipe de Sousa e Melo, +16

Clinical Cancer Research

Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes

Andriy Marusyk, Doris P. Tabassum, Michalina Janiszewska, +17

Cancer Research

Combined image and genomic analysis of high-grade serous ovarian cancer reveals PTEN loss as a common driver event and prognostic classifier

Filipe Correia Martins, Inês de Santiago, Anne Trinh, +11

Genome biology

Intratumor heterogeneity defines treatment‐resistant <scp>HER</scp> 2+ breast tumors

Inga Hansine Rye, Anne Trinh, Anna Barbro Sætersdal, +8

Molecular Oncology

JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States

Laura E. Stevens, Guillermo Peluffo, Xintao Qiu, +30

Cancer Research

Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancer

Jennifer Y. Ge, Shaokun Shu, Mijung Kwon, +18

Nature Communications

Glucose metabolism and NRF2 coordinate the antioxidant response in melanoma resistant to MAPK inhibitors

Raeeka Khamari, Anne Trinh, Pierre Elliott Gabert, +14

Cell Death and Disease